moxifloxacin has been researched along with adenosine monophosphate in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (adenosine monophosphate) | Trials (adenosine monophosphate) | Recent Studies (post-2010) (adenosine monophosphate) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 11,432 | 257 | 2,798 |
| Protein | Taxonomy | moxifloxacin (IC50) | adenosine monophosphate (IC50) |
|---|---|---|---|
| Fructose-1,6-bisphosphatase 1 | Sus scrofa (pig) | 1.3 | |
| Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | 2.6436 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.6 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.1 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.44 | |
| Histamine H3 receptor | Rattus norvegicus (Norway rat) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellibas, SE; Green, CL; Krucoff, MW; Lambe, L; Prats, J; Whellan, DJ; Wijngaard, P | 1 |
1 trial(s) available for moxifloxacin and adenosine monophosphate
| Article | Year |
|---|---|
Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study.
Topics: Adenosine Monophosphate; Adolescent; Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinolines; Time Factors; Young Adult | 2013 |